Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Multisystem inflammatory syndrome in children (MIS-C) possibly secondary to COVID-19 mRNA vaccination

Title: Multisystem inflammatory syndrome in children (MIS-C) possibly secondary to COVID-19 mRNA vaccination
Authors: Wangu, Zoon; Swartz, Hannah; Doherty, Meaghan
Contributors: T.H. Chan School of Medicine; Department of Pediatrics, Division of Pediatric Cardiology; Department of Pediatrics, Division of Pediatric Infectious Diseases and Immunology
Source: BMJ case reports ; 15 ; 3 ; e247176
Publication Year: 2022
Collection: University of Massachusetts, Medical School: eScholarship@UMMS
Subject Terms: COVID-19; Pediatrics; Vaccination; Immunization; Immunology and Infectious Disease; Infectious Disease; Pathological Conditions; Signs and Symptoms; Therapeutics; Virus Diseases
Description: Multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 is a postinfectious condition identified during the COVID-19 pandemic with specific Centers for Disease Control and Prevention and WHO criteria. Theoretical concerns have been raised whether MIS-C might also occur after COVID-19 vaccination, as the pathogenesis of MIS-C is not yet entirely understood. We present a woman in her late teens who developed MIS-C after having received two doses of Pfizer BioNTech COVID-19 vaccine 12 weeks prior, in the setting of documented anti-spike SARS-CoV-2 IgG positive, antinucleocapsid SARS-CoV-2 IgG negative, and multiple negative surveillance SARS-CoV-2 PCRs done in the 12-week period prior to development of MIS-C. While vaccination remains safe and critical in controlling the pandemic, it may be considered as a potential trigger for MIS-C in patients with no history of infection. Further surveillance is necessary to determine whether MIS-C will emerge as a confirmed adverse event after COVID-19 vaccination.
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
ISSN: 29327229
Relation: Link to Article in PubMed; http://hdl.handle.net/20.500.14038/27653; https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1398&context=covid19&unstamped=1; https://escholarship.umassmed.edu/covid19/390; covid19/390
DOI: 10.1136/bcr-2021-247176
Availability: https://doi.org/10.1136/bcr-2021-247176; https://hdl.handle.net/20.500.14038/27653; https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1398&context=covid19&unstamped=1; https://escholarship.umassmed.edu/covid19/390
Rights: Copyright © BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. ; http://creativecommons.org/licenses/by-nc/4.0/
Accession Number: edsbas.912174EB
Database: BASE